Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

MOTS-c Results After 2 Weeks: Comparison

Fasting Glucose 95 mg/dL 88–92 mg/dL Improved GLUT4 expression and insulin-independent glucose uptake in muscle tissue Modest improvement. Meaningful for insulin-resistant individuals, negligible for metabolically healthy users Subjective Energy (1–10 scale) 5

This comparison does not assign a generated winner or score.

  • Fasting Glucose
  • 95 mg/dL
  • 88–92 mg/dL
  • Improved GLUT4 expression and insulin-independent glucose uptake in muscle tissue
  • Modest improvement. Meaningful for insulin-resistant individuals, negligible for metabolically healthy users
  • Subjective Energy (1–10 scale)
  • 5/10
  • 6.5–7/10
  • Increased mitochondrial density (PGC-1α activation) and ATP production capacity
  • Most consistent early marker. Correlates with compliance
  • Body Weight
  • Baseline
  • −0.5 to −1.5 lbs
  • Water weight fluctuation, not fat loss. AMPK doesn't drive caloric deficit on its own
  • Essentially unchanged. Genuine fat loss requires 4+ weeks
  • VO2 Max (mL/kg/min)
  • No change
  • Cardiovascular adaptations lag mitochondrial changes by 3–4 weeks
  • Too early to measure. Aerobic capacity improvements appear after week 4
  • Mitochondrial Biogenesis Markers (PGC-1α)
  • +20–35% (rodent models)
  • Direct AMPK activation of transcription factors regulating mitochondrial replication
  • Real change at cellular level. Not yet reflected in performance metrics
More references

Related material